Lighthouse II Trial Phase 3 underway
Update from Dr Alan Stanley, Consultant Neurologist and Principal Investigator for Lighthouse II Phase 3 clinical trial….
Update from Dr Alan Stanley, Consultant Neurologist and Principal Investigator for Lighthouse II Phase 3 clinical trial….
With Christmas just around the corner MND New Zealand is pleased to offer free access to the…
The inaugural webinar in the newly developed MND New Zealand Community Forum series went successfully, with an…
A new set of clinical guidelines for the management and care of individuals with MND has been…
In his inaugural lecture on 17 October 2022, Professor Shaw gave insight to the remarkable progress recently achieved with a…
Join us for this inaugural webinar in the newly developed MND New Zealand Community Forum where leading…
MND New Zealand welcomes the announcement of Professor Chris Shaw in his appointment to the Hugh Green…
By October of this year, a small group of New Zealanders living with Motor Neuron Disease will…
On Sunday 27th February, our supporters gathered their teams to walk, run, cycle and wheel around their…
MND New Zealand is delighted to announce the appointment of Scott Arrol as the new Chief Executive….
Every year, Walk 2 D’Feet is a special fundraising event providing opportunities for our community to come…